Addendum to Notice of Annual General Meeting
Released
Released
Announcement PDF
5955-01/8924295_3 1
VENARI MINERALS NL
ACN 007 090 904
ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING
Venari Minerals NL (ACN 007 090 904) (Company) gives notice to Shareholders that, in relation to
the Notice of Annual General Meeting dated 9 October 2026 (Notice) in respect of the Company’s
annual general meeting of members to be held at 10:00 am (AEDT) on 23 November 2026 (Meeting),
the Directors have resolved to include Resolutions 5, 6 and 7 within the Notice (Additional
Resolutions) and an additional Section 6 within the Explanatory Statement, additional defined terms
within the Glossary and a new Schedule 1 (to be inserted at the end of the Notice), in each case as
set out in this Addendum.
Capitalised terms in this Addendum have the same meaning as given in the Notice except as
otherwise defined.
This Addendum is supplemental to the Notice and should be read in conjunction with the Notice.
Apart from the amendments set out below, all Resolutions and the Explanatory Statement in the
original Notice remain unchanged.
Replacement Proxy Form
Annexed to this Addendum to the Notice is a replacement Proxy Form (Replacement Proxy Form).
To ensure clarity of voting instructions by Shareholders on the Resolutions to be considered at the
Meeting, Shareholders are advised that:
(a) If you have already completed and returned the Proxy Form annexed with the Notice
(Original Proxy Form) and you wish to cast votes for one or more of the Additional
Resolutions, you must complete and return the Replacement Proxy Form.
(b) If you have already completed and returned the Original Proxy Form and you do not wish
to change your original vote for Resolutions 1 to 4 or vote on the Additional Resolutions,
you do not need to take any action as the earlier submitted Original Proxy Form will be
accepted by the Company for Resolutions 1 to 4 unless you submit a Replacement Proxy
Form. For the sake of clarity, the Company notes that if you do not lodge a Replacement
Proxy Form, you will not have cast a vote on the Additional Resolutions.
(c) If you have not yet completed and returned a Proxy Form and you wish to vote on the
Resolutions in the Notice as supplemented by the Addendum, please complete and return
the Replacement Proxy Form.
Enquiries
Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company
Secretary on +61 2 8046 2799.
5955-01/8924295_3 2
S U P PL E M E N T AR Y B U S I N E S S OF TH E M E E T I NG
The agenda of the Notice is amended by including the following Resolutions:
1. RESOLUTION 5 – APPROVAL TO ISSUE PLACEMENT OPTIONS TO DIRECTOR – ANTHONY
LEIBOWITZ
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is
given for the Company to issue to Anthony Leibowitz (or his nominee(s)) up to
201,250 Options, being one (1) Option for every ten (10) Placement Shares
subscribed for and issued on the terms and conditions set out in the Explanatory
Statement.”
Voting Exclusion Statement:
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of this Resolution
by or on behalf of Anthony Leibowitz (or his nominee(s)) and any other person who will obtain a material
benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary
securities in the Company) or an associate of that person or those person. However, this does not apply to
a vote cast in favour of the Resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(d) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on the Resolution; and
(e) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
2. RESOLUTION 6 – APPROVAL TO ISSUE PLACEMENT OPTIONS TO DIRECTOR – VINCENT FAYAD
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is
given for the Company to issue to Vincent Fayad (or his nominee(s)) up to 100,000
Options, being one (1) Option for every ten (10) Placement Shares subscribed for
and issued on the terms and conditions set out in the Explanatory Statement.”
Voting Exclusion Statement:
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of this Resolution
by or on behalf of Vince Fayad (or his nominee(s)) and any other person who will obtain a material benefit
as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary
securities in the Company) or an associate of that person or those persons. However, this does not apply to
a vote cast in favour of the Resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(d) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on the Resolution; and
(e) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
5955-01/8924295_3 3
3. RESOLUTION 7 – APPROVAL TO ISSUE PLACEMENT OPTIONS TO DIRECTOR – MATTHEW HEALY
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is
given for the Company to issue to Matthew Healy (or his nominee(s)) up to 25,000
Options, being one (1) Option for every ten (10) Placement Shares subscribed for
and issued on the terms and conditions set out in the Explanatory Statement.”
Voting Exclusion Statement:
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of this Resolution
by or on behalf of Matthew Healy (or his nominee(s)) and any other person who will obtain a material
benefit as a result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary
securities in the Company) or an associate of that person or those persons. However, this does not apply to
a vote cast in favour of the Resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in that
way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance
with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a
beneficiary provided the following conditions are met:
(d) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on the Resolution; and
(e) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
5955-01/8924295_3 4
S U P PL E M E N T AR Y E X PL A N A T O R Y S T A T E M E NT
The Explanatory Statement is supplemented by including the following Section:
6. RESOLUTIONS 5 TO 7 – APPROVAL TO ISSUE PLACEMENT OPTIONS TO DIRECTORS
6.1 Background to Placement
As announced on 31 July 2026 and 25 September 2026, the Company raised $4,750,000
(before costs) by way of a placement of 59,375,000 Shares (Placement Shares) at an issue
price of $0.08 per Placement Share (Placement) to sophisticated and professional investors
unrelated to the Company (Unrelated Placement Participants) and to Directors Anthony
Leibowitz, Vincent Fayad and Matthew Healy (or their respective nominees) (Director
Participants).
The Placement Shares were issued in two tranches. The first tranche of 22,095,000
Placement Shares was issued to Unrelated Placement Participants on 31 July 2026 under
the Company’s placement capacity under Listing Rules 7.1 and 7.1A. The second tranche
of 37,280,000 Placement Shares was issued on 25 September 2026 to the remaining
Unrelated Placement Participants and to the Director Participants, following Shareholder
approval obtained at the Company’s general meeting held on 11 September 2026
(General Meeting).
Each Placement Participant was entitled to receive one free attaching Option for every
ten Placement Shares subscribed for and issued to it under the Placement (Placement
Options). Shareholders approved the issue of the Placement Options at the General
Meeting. This included approval for the purposes of Listing Rule 10.11 of the issue of 326,250
Placement Options to the Director Participants (or their respective nominees) (Director
Options).
The Placement Options will be issued under a transaction specific prospectus which the
Company lodged with ASIC on 23 October 2026 (Prospectus).
6.2 General
Listing Rule 10.13.5 requires equity securities approved under Listing Rule 10.11 to be issued
no later than one month after the date of the meeting at which approval is given, unless
ASX grants a waiver.
The Director Options have not been issued. The one month period following the General
Meeting expired on 11 October 2026, so the Company can no longer rely on the approval
given under Resolutions 5 to 7 at the General Meeting to issue the Director Options.
Accordingly, Resolutions 5 to 7 seek Shareholder approval for the purposes of Listing
Rule 10.11 for the issue of up to 326,250 Director Options to the Director Participants (or their
respective nominees), being one Director Option for every ten Placement Shares issued to
the Director Participants under the Placement, on the terms set out below.
Each Director Participant’s participation in the Placement and entitlement to Placement
Options are set out in the table below.
RECIPIENT RESOLUTION PLACEMENT
SHARES*
FUNDS RECEIVED PLACEMENT
OPTION
ENTITLEMENT
Anthony Leibowitz 5 2,012,500 $161,000 201,250
Vincent Fayad 6 1,000,000 $80,000 100,000
Matthew Healy 7 250,000 $20,000 25,000
Total 3,262,500 $261,000 326,250
* Issued on 25 September 2026, following Shareholder approval.
5955-01/8924295_3 5
6.3 Listing Rule 10.11
Listing Rule 10.11 provides that unless one of the exceptions in Listing Rule 10.12 applies, a
listed company must not issue or agree to issue equity securities to:
10.11.1 a related party;
10.11.2 a person who is, or was at any time in the 6 months before the issue or
agreement, a substantial (30%+) holder in the company;
10.11.3 a person who is, or was at any time in the 6 months before the issue or
agreement, a substantial (10%+) holder in the company and who has
nominated a director to the board of the company pursuant to a relevant
agreement which gives them a right or expectation to do so;
10.11.4 an associate of a person referred to in Listing Rules 10.11.1 to 10.11.3; or
10.11.5 a person whose relationship with the company or a person referred to in
Listing Rules 10.11.1 to 10.11.4 is such that, in ASX’s opinion, the issue or
agreement should be approved by its shareholders,
unless it obtains the approval of its shareholders.
The issue falls within Listing Rule 10.11.1 and does not fall within any of the exceptions in
Listing Rule 10.12. It therefore requires the approval of Shareholders under Listing Rule 10.11.
6.4 Chapter 2E of the Corporations Act
Chapter 2E of the Corporations Act requires that, for a public company, or an entity that
the public company controls, to give a financial benefit to a related party of the public
company, the public company or entity must:
(a) obtain the approval of the public company’s members in the manner set out in
sections 217 to 227 of the Corporations Act; and
(b) give the benefit within 15 months following such approval,
unless the giving of the financial benefit falls within an exception set out in sections 210 to
216 of the Corporations Act.
The issue of the Director Options constitutes giving a financial benefit, and each of the
Director Participants is a related party of the Company by virtue of being a Director.
At the General Meeting, Shareholders approved, for the purposes of section 195(4) of the
Corporations Act, the Company’s reliance on the arm’s length terms exception in section
210 of the Corporations Act and the decision not to seek Shareholder approval under
Chapter 2E for the issue of the Director Options. The Director Options will be issued on the
same terms as those considered at the General Meeting. The Company therefore does
not seek that approval again.
6.5 Technical information required by Listing Rule 14.1A
If these Resolutions are passed, the Company will be able to proceed with the issue of the
Placement Options to the Director Participants within one (1) month after the date of the
Meeting. As approval pursuant to Listing Rule 7.1 is not required for the issue (because
approval is being obtained under Listing Rule 10.11), the issue will not use up any of the
Company’s 15% annual placement capacity.
If these Resolutions are not passed, the Company will not be able to proceed with the issue
of Placement Options to the relevant Director Participant and that Director Participant will
not receive the free attaching Placement Options to which the Unrelated Placement
Participants are entitled under the Placement. The Placement Shares already issued to the
Director Participants will not be affected.
5955-01/8924295_3 6
6.6 Technical Information required by Listing Rule 10.13 and section 219 of the Corporations
Act
REQUIRED
INFORMATION
DETAILS
Name of the
persons to whom
Securities will be
issued
The proposed recipients of the Placement Options under
Resolutions 5 to 7 are set out in the table included at Section 6.2
above.
Categorisation
under Listing Rule
10.11
Each of the Director Participants fall within the category set out
in Listing Rule 10.11.1 as they are a related party of the Company
by virtue of being a Director.
Any nominee(s) of the Director Participants who receive
Placement Options may constitute ‘associates’ for the purposes
of Listing Rule 10.11.4.
Number of Securities
and class to be
issued
The maximum number of Placement Options to be issued under
Resolutions 5 to 7 (being the nature of the financial benefit
proposed to be given) and the allocation between the
recipients is set out in the table included at Section 6.2 above.
Terms of Securities The Placement Options will be issued to the Director Participants
on the terms and conditions set out in Schedule 1, being the
same terms as the Placement Options to be issued to the
Unrelated Placement Participants and the Company’s existing
quoted Options (ASX: VMSOA).
Date(s) on or by
which the Securities
will be issued
The Company expects to issue the Placement Options to the
Director Participants under the Prospectus within 5 Business Days
of the Meeting. In any event, the Company will not issue those
Placement Options later than one (1) month after the date of
the Meeting (or such later date to the extent permitted by any
ASX waiver or modification of the Listing Rules).
Price or other
consideration the
Company will
receive for the
Securities
Nil. The Placement Options are free attaching to the Placement
Shares subscribed for by the Director Participants on a 1:10 basis,
as set out in Section 6.2, on the same terms as the Placement
Options issued to the Unrelated Placement Participants.
Purpose of the issue,
including the
intended use of any
funds raised by the
issue
The purpose of the issue is to satisfy the Company’s obligation to
issue free attaching Placement Options to the Director
Participants on the same terms as the Unrelated Placement
Participants. No funds will be raised by the issue of the Placement
Options to the Director Participants. If all of those Placement
Options are exercised, the Company will receive $39,150, which
will be applied towards the Company’s existing business
operations and working capital.
The issue of the Placement Options to the Director Participants
(or their respective nominee(s)) is not intended to remunerate or
incentivise them.
Summary of
material terms of
agreement to issue
The Placement Options are being issued to the Director
Participants on the same terms as to the Unrelated Placement
Participants.
The material terms of the Placement Options are set out in
Schedule 1.
Voting exclusion
statements
Voting exclusion statements apply to these Resolutions.
5955-01/8924295_3 7
S U P PL E M E N T AR Y GL OS S A R Y
The Glossary in the Notice is supplemented by including the following defined terms:
Addendum means this addendum to the Notice.
Additional Resolutions means Resolutions 5, 6 and 7 as set out in this Addendum.
Director Participants has the meaning given in Section 6.1.
General Meeting means the general meeting of the Company held on 11 September 2026.
Placement has the meaning given in Section 6.1.
Placement Options has the meaning given in Section 6.1.
Placement Shares has the meaning given in Section 6.1.
Prospectus has the meaning given in Section 6.1.
Replacement Proxy Form means the replacement proxy form annexed to this Addendum.
Unrelated Placement Participants has the meaning given in Section 6.1.
5955-01/8924295_3 8
S C H E DU L E 1– T E R M S A N D C O N D I T I O N S O F P L AC E M E N T O PT I O NS
The following Schedule is to be inserted at the end of the Notice:
1. Entitlement Each Placement Option entitles the holder to subscribe for one (1) Share
upon exercise of the Placement Option.
2. Exercise Price Subject to paragraph 11, the amount payable upon exercise of each
Placement Option will be $0.12 (Exercise Price).
3. Expiry Date Each Placement Option will expire at 5:00 pm (AEST) on 6 August 2028
(Expiry Date).
A Placement Option not exercised before the Expiry Date will
automatically lapse on the Expiry Date.
4. Exercise Period The Placement Options are exercisable at any time on or prior to the
Expiry Date (Exercise Period).
5. Exercise Notice The Placement Options may be exercised during the Exercise Period by
notice in writing to the Company in the manner specified on the
Placement Option certificate (Exercise Notice) and payment of the
Exercise Price for each Placement Option being exercised in Australian
currency by electronic funds transfer or other means of payment
acceptable to the Company.
6. Exercise Date An Exercise Notice is only effective on and from the later of the date of
receipt of the Exercise Notice and the date of receipt of the payment of
the Exercise Price for each Placement Option being exercised in cleared
funds (Exercise Date).
7. Timing of issue of
Shares on
exercise
Within five Business Days after the Exercise Date, the Company will:
(a) issue the number of Shares required under these terms and
conditions in respect of the number of Options specified in the
Exercise Notice and for which cleared funds have been
received by the Company;
(b) if required, give ASX a notice that complies with section
708A(5)(e) of the Corporations Act, or, if the Company is
unable to issue such a notice, lodge with ASIC a prospectus
prepared in accordance with the Corporations Act and do all
such things necessary to satisfy section 708A(11) of the
Corporations Act to ensure that an offer for sale of the Shares
does not require disclosure to investors; and
(c) if admitted to the official list of ASX at the time, apply for official
quotation on ASX of Shares issued pursuant to the exercise of
the Options.
If a notice delivered under paragraph 7(b) for any reason is not effective
to ensure that an offer for sale of the Shares does not require disclosure
to investors, the Company must, no later than 20 Business Days after
becoming aware of such notice being ineffective, lodge with ASIC a
prospectus prepared in accordance with the Corporations Act and do
all such things necessary to satisfy section 708A(11) of the Corporations
Act to ensure that an offer for sale of the Shares does not require
disclosure to investors.
8. Shares issued on
exercise
Shares issued on exercise of the Options rank equally with the then issued
shares of the Company.
9. Reorganisation If there is a reorganisation of the issued share capital of the Company
(including any subdivision, consolidation, reduction, return or
cancellation of such issued capital of the Company), the rights of the
holder will be changed to the extent necessary to comply with the Listing
Rules applicable to a reorganisation of capital at the time of the
reorganisation.
5955-01/8924295_3 9
10. Participation in
new issues
There are no participation rights or entitlements inherent in the
Placement Options and holders will not be entitled to participate in new
issues of capital offered to Shareholders during the currency of the
Options without exercising the Placement Options.
11. Change in
exercise
price/Adjustment
for rights issue
A Placement Option does not confer the right to a change in Exercise
Price or a change in the number of underlying securities over which the
Option can be exercised.
12. Transferability The Options are transferable subject to any restriction or escrow
arrangements imposed by ASX or under applicable Australian securities
laws.
Venari Minerals NL
ACN 007 090 904
Your Annual General Meeting Proxy Form
Proxy Voting Instructions
Appointment of a Proxy
A proxy is someone you appoint to attend the meeting and vote on your behalf. You don't need to attend
the meeting yourself.
Step 1: Decide Who Will Be Your Proxy
You have two options:
OPTION A: Appoint the Chair of the Meeting
• Simply cross the box marked "The Chair of the Meeting"
• The Chair of the Meeting will vote according to your directions
• If you don't give directions, the Chair of the Meeting will vote undirected proxies in favour of all
Resolutions.
OPTION B: Appoint Someone Else
• Write the full name of the person you want to appoint
• They must attend the meeting to vote on your behalf
• They can be another shareholder or anyone you choose
Important: If you hold 2 or more votes, you can appoint up to TWO proxies by using separate proxy forms.
Step 2: Direct How Your Proxy Should Vote
For each resolution, mark ONE box only with an "X"
FOR AGAINST ABSTAIN
You support the resolution You oppose the resolution You don't want to vote
Voting Exclusions and Prohibitions
Refer to the Notice of Meeting for detailed information of the voting exclusions.
Step 3: Sign the Proxy Form
You must sign the form correctly or it will be invalid:
If you are You must
Individual shareholder Sign your name.
Joint shareholders All must sign.
Corporate shareholder Sign by authorised officer(s). Sole Director/Secretary; or Sole Director (where
no Secretary exists); or two Directors; or Director + Secretary. Print name and
position below signature.
Power of Attorney Sign by authorised attorney. Power of Attorney must be lodged with the Share
Registrar for notation. If not already lodged, attach a certified copy to this form.
Nominee/Custodian Sign by authorised signatory(s). Attach a custodial certificate to this form.
Attending the Meeting
Date and time Monday, 23 November 2026 at 10:00am (AEDT)
Location Ground Floor, 80 Elizabeth Street, Sydney NSW 2000
Arriving at the Meeting &
What to Bring
• Arrive early (15-30mins before the meeting time) to allow for registration
• Go to the registration desk
• Present your proxy form - helps with registration
• Photo ID - may be required
• Corporate Representative Form - if attending on behalf of a company
How to Lodge a Proxy
Online (Recommended Fastest)
Method 1: Scan QR Code
Use your phone or tablet to scan the QR code
on your proxy form.
Method 2: Go to Website
Visit: https://investor.xcend.app/sha
Select: Venari Minerals NL
Enter HIN/SRN: «AccountNumber»
Enter Postcode: if within Australia or
Select Country: if outside Australia
Method 3: Registered Users
Visit https://investor.xcend.app
Enter your username and password, then
click voting
Email
• Scan your completed and signed proxy
Form
• Email to: meetings@xcend.co
Post
Mail your completed and signed proxy form
to:
Xcend Pty Ltd
PO Box R1905
Royal Exchange NSW 1225
Allow extra time for postal delivery
DEADLINE: Saturday, 21 November
2026 at 10:00am (AEDT)
(48 hours before the meeting)
«EntityRegistrationDetailsLine1Envelope»
«EntityRegistrationDetailsLine2Envelope»
«EntityRegistrationDetailsLine3Envelope»
«EntityRegistrationDetailsLine4Envelope»
«EntityRegistrationDetailsLine5Envelope»
«EntityRegistrationDetailsLine6Envelope»
SRN/HIN: «AccountNumber» If Your Address is Incorrect
• Update it in the space provided on the proxy form, OR
• If your shares are broker-sponsored (HIN starts with 'X'), contact your broker
Registered Name & Address
«EntityRegistrationDetailsLine1Envelope»
«EntityRegistrationDetailsLine2Envelope»
«EntityRegistrationDetailsLine3Envelope»
«EntityRegistrationDetailsLine4Envelope»
«EntityRegistrationDetailsLine5Envelope»
«EntityRegistrationDetailsLine6Envelope»
Your Proxy Form - Venari Minerals NL
Annual General Meeting November 2026
Appointment
of
Proxy
I/We, being member(s) of Venari Minerals NL ("Company") and entitled to attend and vote, hereby appoint:
The Chair of the Meeting
(Mark box with an X)
OR
Name of Proxy (If you are NOT appointing the Chair of
the Meeting, write the name of the person or body
corporate)
or failing the person or body corporate named, or if no person or body corporate is named above, the Chair of the Meeting, as my/our proxy to
vote on my/our behalf at the Annual General Meeting on Monday, 23 November 2026 at 10:00am (AEDT) at Ground Floor, 80 Elizabeth Street, Sydney
NSW 2000 (including any postponement or adjournment).
The proxy must vote as directed below or, if no directions are given, may vote as they see fit to the extent permitted by law.
The Chair of the Meeting intends to vote undirected proxies in FAVOUR of all Resolutions.
Authority for Chair to vote undirected proxies on remuneration related resolutions
Where I/we have appointed the Chair as my/our proxy (or where the Chair becomes my/our proxy by default), I/we expressly authorise the Chair
to exercise my/our proxy on Resolutions 1 and 4 (except where I/we have indicated a different voting intention below) even though Resolutions 1
and 4 are connected directly or indirectly with the remuneration of a member of the Key Management Personnel, which includes the Chair.
Provide
Your
Proxy
Voting
Directions
For each resolution: Mark ONE box with an "X" to vote all shares OR write number of shares in each box to split your vote.
Resolutions For Against Abstain
1 Adoption of Remuneration Report  Â
2 Re-election of Mr Anthony Leibowitz
3 Approval of 7.1A Mandate
4 Approval to Issue Securities to Unrelated Parties under an Incentive Plan
5 Approval to Issue Placement Options to Director – Anthony Leibowitz
6 Approval to Issue Placement Options to Director – Vincent Fayad
7 Approval to Issue Placement Options to Director – Matthew Healy
Please
Sign
and
Return
*
This
section
must
be
completed.
By signing this form, I/we confirm my/our authority to appoint the named proxy with voting directions as indicated above and hereby revoke
any previously lodged proxy for this meeting.
Securityholder 1
Sole Director/Sole Company Secretary
Joint Securityholder 2
Director/Company Secretary
Joint Securityholder 3
Director/Company Secretary
Print Name of Securityholder Print Name of Securityholder Print Name of Securityholder
Update your communication details:
Email Address Phone Number (Contactable during business hours)
By providing your email address, you consent to receive all future Securityholder communications electronically.
Share your feedback
Discover